UST, a global provider of AI-led digital and technology transformation services, has entered into a Memorandum of Understanding with the IIT Madras Incubation Cell (IITMIC) to strengthen innovation, entrepreneurship, and research-based solutions in the healthcare and life sciences space. IITMIC is widely regarded as one of India’s foremost deep-tech startup ecosystems, anchored within IIT Madras.
The agreement sets up a collaborative framework through which UST and IITMIC will jointly support high-potential startups by combining industry insight with academic research and incubation expertise. The partnership is designed to enable structured yet adaptable engagement, covering mentorship, access to funding, pilot programs, proof-of-concept development, strategic alliances, and market entry support. By aligning corporate capabilities with the incubation ecosystem, the collaboration aims to accelerate the journey of promising ideas from early development to real-world deployment.
As an initial initiative under this alliance, UST and IITMIC jointly hosted the “Pitch to Win: Pharma 4.0 Edition,” with Pfizer participating as the Knowledge Partner and AWS as the Technology Partner. The innovation challenge attracted more than 90 applications from startups across 32 Indian cities, highlighting the growing depth and diversity of the country’s healthcare and life sciences startup landscape. Following an intensive evaluation process, ten shortlisted startups received month-long mentorship from UST before presenting their solutions to a jury panel during the final pitch event at IITMIC in Chennai.
Nucleo-Vir Therapeutics emerged as the winner of the challenge, followed by ChemBioSens as the first runner-up and LN Infosphere Tech Transformers as the second runner-up. The three startups were awarded cash prizes of ₹1.25 lakh, ₹75,000, and ₹50,000 respectively. In addition, UST has committed conditional funding of up to ₹45 lakh for the winners, along with go-to-market assistance and broader strategic support.
Commenting on the partnership, Manu Gopinath, President of UST, said the collaboration reflects a long-term commitment to nurturing deep-tech innovation by supporting founders who are building research-driven, high-impact solutions. He highlighted that combining IITMIC’s incubation strength with UST’s global reach and industry partnerships creates a strong platform to translate breakthrough ideas into scalable technologies.
Dr Tamaswati Ghosh, CEO of IIT Madras Incubation Cell, noted that the partnership aligns with IITMIC’s mission to strengthen India’s deep-tech ecosystem, particularly in healthcare and life sciences. She added that initiatives like the Pharma 4.0 edition help connect startups with industry, investors, and academia to scale solutions with global relevance.
The collaboration reinforces UST’s focus on advancing India’s Life Sciences 4.0 ecosystem by enabling innovation that is research-led, industry-aligned, and built for meaningful impact. Founded in 1999, UST partners with leading global companies to drive transformation and make a tangible impact. With over 30,000 employees across 30+ countries, UST delivers digital solutions, engineering services, and innovation platforms to solve complex challenges and drive disruptive change. By combining expertise, innovation, and agility, UST creates measurable value and lasting impact for its clients, customers, and communities worldwide.
